{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:12:57Z","timestamp":1792462377736,"version":"4.5.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    Atrial fibrillation is a major cause of ischemic stroke and systemic embolism. Oral anticoagulants (OACs) play a crucial role in preventing thromboembolic events in high-risk patients. However, evidence regarding initiation of OAC in patients with a prior intracranial hemorrhage (ICH) remains limited. We systematically searched PubMed, Scopus, and Cochrane Library for relevant articles published up to September 25, 2025, to evaluate the efficacy and safety of OACs in patients with atrial fibrillation and a history of ICH. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using a random-effects model. A total of 9181 patients were included. OAC therapy significantly reduced ischemic stroke (RR: 0.38; 95% CI: 0.26\u20130.55;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.00001) and ischemic stroke\/systemic embolism (RR: 0.47; 95% CI: 0.36\u20130.61;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.00001) when compared with no OAC therapy. OAC also reduced stroke-related mortality (RR: 0.55; 95% CI: 0.31\u20130.99;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.04), all-cause mortality (RR: 0.68; 95% CI: 0.57\u20130.81;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.0001), and major adverse cardiac events (RR: 0.69; 95% CI: 0.51\u20130.94;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.02). However, its use was associated with a higher risk of major extracranial bleeding (RR: 1.70; 95% CI: 1.04\u20132.77;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.03). There was no significant association between the use of OAC and recurrence of ICH (RR: 1.21; 95% CI: 0.69\u20132.13;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.50). In conclusion, patients with previously documented ICH, OAC therapy substantially lowers the risk of ischemic stroke, systemic embolism, and major adverse cardiac events. There is no significant increase in intracranial bleeds with OAC. Prospective studies are needed to further refine the decision-making.\n                  <\/jats:p>","DOI":"10.1097\/crd.0000000000001213","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:00:23Z","timestamp":1771563623000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Oral Anticoagulation Versus No Anticoagulation in Patients of Atrial Fibrillation With Prior History of Intracranial Hemorrhage: A Meta-Analysis"],"prefix":"10.1097","author":[{"given":"Mayank","family":"Jha","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Government Medical College and New Civil Hospital, Surat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Chahodiya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Government Medical College and New Civil Hospital, Surat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxi","family":"Thaker","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Government Medical College and New Civil Hospital, Surat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kruti","family":"Matawala","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Government Medical College and New Civil Hospital, Surat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahreena","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow Medical College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshilkumar","family":"Maheta","sequence":"additional","affiliation":[{"name":"Department of Public Health, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth Pravin","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Landmark Medical Center, New York Medical College, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid","family":"Siddiq","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Landmark Medical Center, New York Medical College\/, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"R1-20260220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge.","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"R2-20260220","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/heartjnl-2024-324848","article-title":"Anticoagulation in patients with low-burden atrial fibrillation: new evidence focussing on device-detected AF.","volume":"111","author":"Becher","year":"2025","journal-title":"Heart"},{"key":"R3-20260220","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.2024.22451","article-title":"Atrial fibrillation: a review.","volume":"333","author":"Ko","year":"2025","journal-title":"JAMA"},{"key":"R4-20260220","doi-asserted-by":"crossref","first-page":"102181","DOI":"10.1016\/j.cpcardiol.2023.102181","article-title":"Atrial fibrillation and stroke: state-of-the-art and future directions.","volume":"49","author":"Elsheikh","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"R5-20260220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","article-title":"Secondary stroke prevention in people with atrial fibrillation: treatments and trials.","volume":"23","author":"Seiffge","year":"2024","journal-title":"Lancet Neurol"},{"key":"R6-20260220","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"R7-20260220","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"R8-20260220","doi-asserted-by":"crossref","first-page":"1122564","DOI":"10.3389\/fphar.2023.1122564","article-title":"Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: a systematic review and meta-analysis.","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Pharmacol"},{"key":"R9-20260220","doi-asserted-by":"crossref","first-page":"e000279","DOI":"10.1136\/openhrt-2015-000279","article-title":"NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis.","volume":"3","author":"Hicks","year":"2016","journal-title":"Open Heart"},{"key":"R10-20260220","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaneurol.2019.2099","article-title":"Clinical effectiveness of direct oral anticoagulants vs warfarin in older patients with atrial fibrillation and ischemic stroke: findings from the patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study.","volume":"76","author":"Xian","year":"2019","journal-title":"JAMA Neurol"},{"key":"R11-20260220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1212\/CPJ.0000000000000425","article-title":"Anticoagulation for atrial fibrillation after intracranial hemorrhage: a systematic review.","volume":"8","author":"Hawkes","year":"2018","journal-title":"Neurol Clin Pract"},{"key":"R12-20260220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","article-title":"Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study.","volume":"132","author":"Nielsen","year":"2015","journal-title":"Circulation"},{"key":"R13-20260220","doi-asserted-by":"crossref","first-page":"1061618","DOI":"10.3389\/fcvm.2023.1061618","article-title":"Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation.","volume":"10","author":"Luc\u00e0","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R14-20260220","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1080\/14656566.2020.1789099","article-title":"Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy.","volume":"21","author":"Rivera-Caravaca","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"R15-20260220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11883-018-0733-y","article-title":"Anticoagulation resumption after intracerebral hemorrhage.","volume":"20","author":"Li","year":"2018","journal-title":"Curr Atheroscler Rep"},{"key":"R16-20260220","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","article-title":"Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis.","volume":"48","author":"Murthy","year":"2017","journal-title":"Stroke"},{"key":"R17-20260220","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R19-20260220","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","article-title":"Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.","volume":"405","author":"Veltkamp","year":"2025","journal-title":"Lancet (Lond)"},{"key":"R20-20260220","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","article-title":"Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.","volume":"20","author":"Schreuder","year":"2021","journal-title":"Lancet Neurol"},{"key":"R21-20260220","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial.","volume":"20","author":"Al-Shahi Salman","year":"2021","journal-title":"Lancet Neurol"},{"key":"R22-20260220","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation.","volume":"383","author":"Okumura","year":"2020","journal-title":"N Engl J Med"},{"key":"R23-20260220","doi-asserted-by":"crossref","first-page":"e022849","DOI":"10.1161\/JAHA.121.022849","article-title":"Post\u2010intracranial hemorrhage antithrombotic therapy in patients with atrial fibrillation.","volume":"11","author":"Lin","year":"2022","journal-title":"JAHA"},{"key":"R24-20260220","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s10072-021-05602-7","article-title":"Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between scylla and charybdis.","volume":"43","author":"Abrantes","year":"2022","journal-title":"Neurol Sci"},{"key":"R25-20260220","first-page":"3","article-title":"Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality.","volume":"7","author":"Komen","year":"2021","journal-title":"Eur Heart J"},{"key":"R26-20260220","doi-asserted-by":"crossref","first-page":"e26945","DOI":"10.1097\/MD.0000000000026945","article-title":"Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage.","volume":"100","author":"Wu","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R27-20260220","doi-asserted-by":"crossref","first-page":"100222","DOI":"10.1016\/j.ensci.2020.100222","article-title":"Long-term outcome of resuming anticoagulation after anticoagulation-associated intracerebral hemorrhage.","volume":"18","author":"Sadighi","year":"2020","journal-title":"eNeurologicalSci"},{"key":"R28-20260220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5853\/jos.2018.02243","article-title":"Anticoagulants in older patients with nonvalvular atrial fibrillation after intracranial hemorrhage.","volume":"21","author":"Perreault","year":"2019","journal-title":"J Stroke"},{"key":"R29-20260220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-0038-1627454","article-title":"Anticoagulants resumption after warfarin-related intracerebral haemorrhage: the Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy).","volume":"118","author":"Poli","year":"2018","journal-title":"Thromb Haemost"},{"key":"R30-20260220","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.hrthm.2016.05.016","article-title":"Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage.","volume":"13","author":"Park","year":"2016","journal-title":"Heart Rhythm"},{"issue":"1_suppl","key":"R31-20260220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/23969873241296803","article-title":"Oral anticoagulation following intracranial haemorrhage in patients with atrial fibrillation.","volume":"10","author":"Shoamanesh","year":"2025","journal-title":"Eur Stroke J"},{"key":"R32-20260220","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fneur.2020.00760","article-title":"Reversal treatment in oral anticoagulant-related intracerebral hemorrhage-an observational study based on the swedish stroke register.","volume":"11","author":"Apostolaki-Hansson","year":"2020","journal-title":"Front Neurol"},{"key":"R33-20260220","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000321766","article-title":"Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage.","volume":"31","author":"Kuwashiro","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"R34-20260220","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1747-4949.2012.00926.x","article-title":"Improved survival of patients with warfarin-associated intracerebral haemorrhage: a retrospective longitudinal population-based study.","volume":"10","author":"Huhtakangas","year":"2015","journal-title":"Int J Stroke"},{"key":"R35-20260220","doi-asserted-by":"crossref","first-page":"10760296251368889","DOI":"10.1177\/10760296251368889","article-title":"Oral anticoagulant therapy in patients with atrial fibrillation after intracranial hemorrhage: a meta-analysis of randomized controlled trials.","volume":"31","author":"Zhang","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"key":"R36-20260220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5937\/arhfarm75-57069","article-title":"Bleeding risk and drug interactions in patients with atrial fibrillation taking oral anticoagulants.","volume":"75","author":"Kova\u010devi\u0107","year":"2025","journal-title":"Arhiv za farmaciju"},{"key":"R37-20260220","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.0000000000004362","article-title":"Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.","volume":"89","author":"Tsivgoulis","year":"2017","journal-title":"Neurology"},{"key":"R38-20260220","doi-asserted-by":"crossref","first-page":"e1143","DOI":"10.1212\/WNL.0000000000005207","article-title":"Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin.","volume":"90","author":"Kurogi","year":"2018","journal-title":"Neurology"},{"key":"R39-20260220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000462985","article-title":"Volume and characteristics of intracerebral hemorrhage with direct oral anticoagulants in comparison with warfarin.","volume":"7","author":"Adachi","year":"2017","journal-title":"Cerebrovasc Dis Extra"},{"key":"R40-20260220","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1212\/WNL.0000000000002310","article-title":"Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.","volume":"86","author":"Wilson","year":"2016","journal-title":"Neurology"},{"key":"R41-20260220","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jama.2017.21917","article-title":"Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality.","volume":"319","author":"Inohara","year":"2018","journal-title":"JAMA"},{"key":"R42-20260220","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.025","article-title":"Intracerebral hemorrhagic expansion occurs in patients using non-vitamin K antagonist oral anticoagulants comparable with patients using warfarin.","volume":"26","author":"Melmed","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R43-20260220","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1747-4949.2012.00839.x","article-title":"Pathophysiologic cascades in ischemic stroke.","volume":"7","author":"Xing","year":"2012","journal-title":"Int J Stroke"},{"issue":"Suppl 1","key":"R44-20260220","first-page":"S52","article-title":"Cardioembolic stroke: an update on etiology, diagnosis and management.","volume":"11","author":"Leary","year":"2008","journal-title":"Ann Indian Acad Neurol"},{"key":"R45-20260220","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/brainsci15050454","article-title":"Ischemic stroke in patients under oral anticoagulation: the Achilles heel of atrial fibrillation management.","volume":"15","author":"Dimitriadis","year":"2025","journal-title":"Brain Sci"},{"key":"R46-20260220","first-page":"S1109966625001794","article-title":"Ischemic stroke in patients with atrial fibrillation on oral anticoagulants: characteristics and long-term outcomes.","volume":"75","author":"Korompoki","year":"2025","journal-title":"Hellenic J Cardiol"},{"key":"R47-20260220","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/ejh.13737","article-title":"Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia.","volume":"108","author":"Cornelissen","year":"2022","journal-title":"Eur J Haematol"},{"key":"R48-20260220","first-page":"1","article-title":"Anticoagulant therapy for acute coronary syndromes.","volume":"1","author":"Onwordi","year":"2018","journal-title":"Interv Cardiol Rev"},{"key":"R49-20260220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ihj.2024.07.001","article-title":"Anticoagulant and antiplatelet treatment effects on the incidence of major cardiovascular events in patients with coronary artery ectasia: an updated systematic review.","volume":"76","author":"Amirpour","year":"2024","journal-title":"Indian Heart J"},{"key":"R50-20260220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review.","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"R51-20260220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/fcp.12063","article-title":"Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade.","volume":"28","author":"Atar","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"R52-20260220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","article-title":"Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation.","volume":"48","author":"Pennlert","year":"2017","journal-title":"Stroke"},{"key":"R53-20260220","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.0000000000000245","article-title":"Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study.","volume":"82","author":"Poli","year":"2014","journal-title":"Neurology"},{"key":"R54-20260220","doi-asserted-by":"crossref","first-page":"e007034","DOI":"10.1161\/JAHA.117.007034","article-title":"Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin\u2010K oral anticoagulants (RAF\u2010NOACs) study.","volume":"6","author":"Paciaroni","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R55-20260220","doi-asserted-by":"crossref","first-page":"1399955","DOI":"10.3389\/fphar.2024.1399955","article-title":"Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort.","volume":"15","author":"Jeong","year":"2024","journal-title":"Front Pharmacol"},{"key":"R56-20260220","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.hrthm.2025.06.023","article-title":"Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage.","volume":"22","author":"Kaisaier","year":"2025","journal-title":"Heart Rhythm"},{"key":"R57-20260220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2024.06.022","article-title":"Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: a report from a prospective European observational registry.","volume":"128","author":"Mei","year":"2024","journal-title":"Eur J Intern Med"},{"key":"R58-20260220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2261-12-98","article-title":"Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland.","volume":"12","author":"Labuz-Roszak","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"R59-20260220","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.amepre.2007.01.010","article-title":"Aspirin use among adults aged 40 and older in the United States.","volume":"32","author":"Pignone","year":"2007","journal-title":"Am J Prev Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:00:32Z","timestamp":1771563632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":58,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001213","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}